BridgeMD
New treatment option for Cerebral Palsy (CP)
Official title Effects of Motor Imagery and Action Observation on Motor Function in Unilateral Cerebral Palsy
ClinicalTrials.gov ID: NCT07612371
What this study is testing
- What it's testing
- The aim of this study is to evaluate the effects of action observation therapy and motor imagery methods, provided in addition to a conventional physiotherapy and rehabilitation program, on gross motor function, upper and lower extremity functional skills, and quality of life in children with cerebral palsy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 7 to 16
You may be able to join if
- Being between 7 and 16 years of age
- Having a diagnosis of unilateral cerebral palsy made by a pediatric neurologist
- Being classified at levels I-II of the Gross Motor Function Classification System (GMFCS)
- Scoring above 24 on the Mini-Mental State Examination for Children
- Having no cognitive impairments (i.e., possessing an appropriate cognitive level to follow task instructions)
You likely can't join if
- Children with uncontrolled seizures
- Children who have received motor imagery training or action observation therapy within the last 6 months
- Children with contractures
- Children with severe visual and/or hearing impairments
- Being classified at levels III, IV, or V according to the GMFCS
- Scoring below 24 on the Mini-Mental State Examination for Children
See the full eligibility criteria
- Being between 7 and 16 years of age
- Having a diagnosis of unilateral cerebral palsy made by a pediatric neurologist
- Being classified at levels I-II of the Gross Motor Function Classification System (GMFCS)
- Scoring above 24 on the Mini-Mental State Examination for Children
- Having no cognitive impairments (i.e., possessing an appropriate cognitive level to follow task instructions)
- Willingness to participate in the study (child and family)
- Being classified at levels I-III of the Manual Ability Classification System (MACS) -Being classified at levels I-III of the Communication Function Classification System (CFCS) -
- Children with uncontrolled seizures
- Children who have received motor imagery training or action observation therapy within the last 6 months
- Children with contractures
- Children with severe visual and/or hearing impairments
- Being classified at levels III, IV, or V according to the GMFCS
- Scoring below 24 on the Mini-Mental State Examination for Children
- Being classified at levels IV-V of the Manual Ability Classification System (MACS)
- Having undergone orthopedic surgery or botulinum toxin (Botox) treatment within the last 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 7 years to 16 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.